Clinical Trial Update: ctDNA in Subjects With Muscle-invasive Bladder Cancer Treated With Trimodality Therapy

View source ↗

Summary

Clinical trial update reporting ctDNA findings in patients with muscle-invasive bladder cancer treated with trimodality therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Muscle-invasive Bladder Cancer

Snippet

Sponsor: UNC Lineberger Comprehensive Cancer Center | Conditions: Bladder Cancer, Muscle-Invasive Bladder Carcinoma | Status: COMPLETED